Global Law Experts
Discover independent Life Sciences lawyers worldwide on Global Law Experts. Explore recognition and expertise in the field of Life Sciences.
Life sciences law operates at the intersection of biology, medicine, and technology, governing the highly regulated path from laboratory discovery to global market access. This multifaceted practice area covers the entire product lifecycle for pharmaceuticals, biotechnology, and medical devices. Attorneys provide the essential framework for navigating the rigorous approval processes of bodies like the FDA or EMA, managing complex clinical trial agreements, and ensuring compliance with stringent healthcare fraud and abuse laws.
Global Law Experts connects you with premier life sciences specialists who possess the deep technical expertise required to handle high-stakes matters. These lawyers are established experts within their own fields, offering the strategic foresight needed for cross-border licensing, patent linkage strategies, and the data privacy nuances of genomic research. Whether you are a startup securing Series A funding for a novel therapy or a multinational corporation managing a complex portfolio of biosimilars, they provide the strategic advocacy needed to protect your intellectual property and ensure patient access.
Every GLE member is independently vetted by practice area and jurisdiction.
A Life Sciences lawyer supports a wide range of companies that research, develop, or manufacture health products. This primarily includes the “Big Three” sectors of pharmaceuticals, biotechnology, and medical devices, but the field has rapidly expanded to include digital health, genomics, and agricultural tech (AgTech). Since the global life sciences legal market is largely driven by innovation, lawyers in this space also represent university research labs and venture capital funds.
You effectively need legal guidance at every single step of the five-stage process, starting from the initial Discovery phase where intellectual property must be secured. The need for counsel intensifies during Pre-clinical and Clinical trials to manage patient safety contracts, peaks during the Regulatory Review phase to handle government queries, and continues through Post-Market monitoring to defend against safety lawsuits.
A lawyer acts as your strategic interpreter during the approval process, helping you choose the correct pathway—such as the 505(b)(2) route in the US—to avoid unnecessary clinical trials. They review your application to ensure your data presentation meets the strict statutory standards of safety and efficacy, which is critical given that the US FDA approved only 50 new drugs in 2024. If the agency issues a Complete Response Letter (a rejection), a lawyer helps you draft the legal arguments to appeal the decision or restructure your resubmission to fix the identified deficiencies.
The biggest hurdle in biotech is the “subject matter eligibility” rule, which essentially states you cannot patent a product of nature. Since the US Supreme Court’s 2013 Myriad Genetics ruling, you cannot patent a naturally occurring human gene even if you isolate it, meaning lawyers must draft claims that focus on the non-natural methods of using or modifying the gene (like cDNA) rather than the gene itself. This creates a complex legal minefield where a single poorly written sentence can render a billion-dollar invention unpatentable because it sounds too much like a natural discovery.
Yes, because the CTA dictates who is financially responsible if a volunteer gets hurt during your study. A lawyer negotiates the “Subject Injury” and “Indemnification” clauses to ensure that your company is not liable for medical costs resulting from the trial site’s negligence rather than your drug. Furthermore, they protect your ownership of the data generated during the trial, preventing the hospital or university running the study from publishing your trade secrets before you have a chance to file for patent protection.
Lawyers defend device manufacturers primarily against “strict liability” claims, where a plaintiff does not need to prove you were negligent, only that the product was defective and caused harm. They often use the “preemption” defense for Class III devices (the highest risk category), arguing that because the FDA rigorously approved the device’s specific design and warnings, state laws cannot impose additional liability requirements. This defense is vital in an industry where large-scale product liability settlements can reach billions of dollars.
The rules depend entirely on where your audience is located due to a massive regulatory divide. In the United States, lawyers ensure your ads meet the “fair balance” standard, meaning the presentation of risks must be as prominent as the benefits; however, in the United Kingdom, direct-to-consumer advertising for prescription medicine is strictly banned to protect public health. A lawyer reviews every piece of marketing material to ensure you don’t accidentally trigger a federal investigation for “off-label promotion,” which occurs if you market a drug for a use the government hasn’t explicitly approved.
These deals are structured around the Bayh-Dole Act, a US law that allows universities to own the patents for inventions created with federal funding. A lawyer negotiates a “license agreement” where the university keeps the patent title but grants the pharma company the exclusive commercial rights to develop and sell the final product. The contract must carefully define “Milestone Payments” and “Royalties” to ensure the university gets paid fairly if the drug succeeds without crippling the company’s profit margins.
A Life Sciences lawyer supports a wide range of companies that research, develop, or manufacture health products. This primarily includes the "Big Three" sectors of pharmaceuticals, biotechnology, and medical devices, but the field has rapidly expanded to include digital health, genomics, and agricultural tech (AgTech). Since the global life sciences legal market is largely driven by innovation, lawyers in this space also represent university research labs and venture capital funds.
You effectively need legal guidance at every single step of the five-stage process, starting from the initial Discovery phase where intellectual property must be secured. The need for counsel intensifies during Pre-clinical and Clinical trials to manage patient safety contracts, peaks during the Regulatory Review phase to handle government queries, and continues through Post-Market monitoring to defend against safety lawsuits.
A lawyer acts as your strategic interpreter during the approval process, helping you choose the correct pathway—such as the 505(b)(2) route in the US—to avoid unnecessary clinical trials. They review your application to ensure your data presentation meets the strict statutory standards of safety and efficacy, which is critical given that the US FDA approved only 50 new drugs in 2024. If the agency issues a Complete Response Letter (a rejection), a lawyer helps you draft the legal arguments to appeal the decision or restructure your resubmission to fix the identified deficiencies.
The biggest hurdle in biotech is the "subject matter eligibility" rule, which essentially states you cannot patent a product of nature. Since the US Supreme Court's 2013 Myriad Genetics ruling, you cannot patent a naturally occurring human gene even if you isolate it, meaning lawyers must draft claims that focus on the non-natural methods of using or modifying the gene (like cDNA) rather than the gene itself. This creates a complex legal minefield where a single poorly written sentence can render a billion-dollar invention unpatentable because it sounds too much like a natural discovery.
Yes, because the CTA dictates who is financially responsible if a volunteer gets hurt during your study. A lawyer negotiates the "Subject Injury" and "Indemnification" clauses to ensure that your company is not liable for medical costs resulting from the trial site's negligence rather than your drug. Furthermore, they protect your ownership of the data generated during the trial, preventing the hospital or university running the study from publishing your trade secrets before you have a chance to file for patent protection.
Lawyers defend device manufacturers primarily against "strict liability" claims, where a plaintiff does not need to prove you were negligent, only that the product was defective and caused harm. They often use the "preemption" defense for Class III devices (the highest risk category), arguing that because the FDA rigorously approved the device's specific design and warnings, state laws cannot impose additional liability requirements. This defense is vital in an industry where large-scale product liability settlements can reach billions of dollars.
The rules depend entirely on where your audience is located due to a massive regulatory divide. In the United States, lawyers ensure your ads meet the "fair balance" standard, meaning the presentation of risks must be as prominent as the benefits; however, in the United Kingdom, direct-to-consumer advertising for prescription medicine is strictly banned to protect public health. A lawyer reviews every piece of marketing material to ensure you don't accidentally trigger a federal investigation for "off-label promotion," which occurs if you market a drug for a use the government hasn't explicitly approved.
These deals are structured around the Bayh-Dole Act, a US law that allows universities to own the patents for inventions created with federal funding. A lawyer negotiates a "license agreement" where the university keeps the patent title but grants the pharma company the exclusive commercial rights to develop and sell the final product. The contract must carefully define "Milestone Payments" and "Royalties" to ensure the university gets paid fairly if the drug succeeds without crippling the company’s profit margins.
Global Law Experts is dedicated to providing exceptional legal services to clients around the world. With a vast network of highly skilled and experienced lawyers, we are committed to delivering innovative and tailored solutions to meet the diverse needs of our clients in various jurisdictions.
Global Law Experts is dedicated to providing exceptional legal services to clients around the world. With a vast network of highly skilled and experienced lawyers, we are committed to delivering innovative and tailored solutions to meet the diverse needs of our clients in various jurisdictions.
Send welcome message
